TITLE

NAFARELIN

PUB. DATE
January 2007
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p578
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on nafarelin, a drug used for the treatment of endometriosis to relieve pain and reduce scattered implants of endometrial tissue. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug with other drugs is also mentioned.
ACCESSION #
23970526

 

Related Articles

  • NAFARELIN.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p578 

    The article presents information on nafarelin, a drug used for the treatment of endometriosis to relieve pain and reduce scattered implants of endometrial tissue. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions...

  • nafarelin.  // Davis's Drug Guide for Nurses, 9th edition;2005, p723 

    Presents information on nafarelin, a gonadotropin-releasing hormone used for managing endometriosis. Pharmacokinetics; Adverse reactions and side effects; Drug interactions; Required dosage of the drug for adults.

  • OB/GYN.  // Monthly Prescribing Reference;Feb2011, Vol. 27 Issue 2, p278 

    A part of the periodical "Monthly Prescribing Reference" for February 2011 is presented. It offers an overview of pharmacological treatments for female reproductive system disorders including vaginal infections, dysmenorrhea and endometriosis. These include Lupron Depot from Abbott, Celebrex...

  • Current and future medical treatment of adenomyosis. Tosti, Claudia; Troìa, Libera; Vannuccini, Silvia; Lazzeri, Lucia; Luisi, Stefano; Petraglia, Felice // Journal of Endometriosis & Pelvic Pain Disorders;Oct-Dec2016, Vol. 8 Issue 4, p127 

    Adenomyosis is a benign gynecological disorder associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia and infertility, requiring a life-long management plan through medical or surgical treatment. The choice depends on woman's age, reproductive status and clinical symptoms. However,...

  • nafarelin.  // Davis's Drug Guide for Nurses, 10th edition;2007, p830 

    The article presents pharmacological information on nafarelin, a gonadotropin-releasing hormone used for the management of endometriosis and central precocious puberty in children. It increases pituitary production of luteinizing hormone. Its adverse reactions include emotional instability,...

  • Triptorelin.  // Reactions Weekly;12/8/2012, Issue 1431, p37 

    The article describes a case of osteopenia in a patient following administration of triptorelin for deviant sexual behaviour.

  • Leuprorelin.  // Reactions Weekly;2/20/2010, Issue 1289, p27 

    The article describes the case of an 80-year-old man who experienced atopic dermatitis while receiving leuprorelin acetate.

  • Leuprorelin.  // Reactions Weekly;Apr2014, Vol. 1496 Issue 1, p28 

    The article presents a case study of a 62-year-old man who experienced an acute manic episode during treatment with leuprorelin.

  • Leuprorelin.  // Reactions Weekly;Apr2014, Vol. 1496 Issue 1, p28 

    The article presents a case study of a transgender female-to- male patient who developed sterile abscesses while receiving leuprorelin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics